Login   |  Users Online: 831 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts
RESEARCH ARTICLE
Year : 2008  |  Volume : 29  |  Issue : 4  |  Page : 243-247

A Clinical Study on Pothaki - Trachoma


1 Ph.D. Scholar, Dept. of Shalakya Tantra, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
2 Reader, Dept. of Shalakya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
3 Honorary Ophthalmologist, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India

Correspondence Address:
Narayan Bavalatti
Ph.D. Scholar, Dept. of Shalakya Tantra, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Pothaki - Trachoma is one of the diseases, having multiple follicles in the lids resembling red mustard seeds, occurring mainly due to vitiation of Kapha Dosha. Trachoma is a specific communicable keratoconjunctivitis usually of chronic nature caused by the Chlamydia trachomatis. It is primarily affecting the superficial epithelium, characterized by formation of follicles, papillary hyperplasia and pannus; the natural resolution of which is by cicatrisation involving potentially considerable visual disability. The study was done on 49 patients of Pothaki-Trachoma. Pippalyadi eye drops were instilled in group A and Ofloxacin in group B as a standard control. After enrollment of the patients in the study, vital signs and symptoms of Pothaki-Trachoma such as discharge, itching, heaviness, swelling etc. were studied before and after the treatment. Amongst the registered patients 16 patients completed the course of treatment in group A and 15 patients in group B. In group A, 43.75% patients got moderate improvement, 50.00% got mild improvement and 6.25% were unchanged, whereas none of the patients were completely cured. In group B, 26.67% got marked improvement, 53.33% were moderately improved and 20% got mild improvement.


[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed853    
    Printed59    
    Emailed2    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal